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Cerebrospinal fluid lactate dehydrogenase, proteins and electrolytes as markers of central nervous system involvement in patients with Acute lymphocytic leukemia.
Deepa Mittal,Veena S Ghalaut, P S Ghalaut, Shashi Rao Sharda Hospitals, Hindustan Institute of Medical Sciences, Greater Noida, UP.
Central nervous system (CNS) involvement is common in hematooncologic diseases especially in patients with acute lymphocytic leukemia (ALL). Currently available modalities have limited value in diagnosing CNS involvement in early stages of disease. Raised cerebrospinal fluid (CSF) total lactate dehydrogenase (LDH) levels can predict CNS involvement in patients with various neurological disorders including CNS leukemia. The current study evaluates CSF total LDH, proteins and electrolytes (Na+, K+ and Cl-) as markers of CNS involvement in patients with ALL.
The study was conducted in 23 consecutive freshly diagnosed patients of ALL without any previous CNS disease. Analysis of CSF was done for total LDH, proteins and electrolytes in all the patients before the start of chemotherapy and when the patients were in remission or six weeks after chemotherapy whichever was earlier. 23 age and sex matched controls were also studied to set the normal reference range. The results were analyzed statistically by Student 't' test and Coefficient of co-relation between CSF LDH and CSF protein in patients with raised CSF LDH at the time of presentation was also calculated CSF LDH was elevated in 4 out of 6 patients with signs and symptoms of CNS involvement and 3 of these patients also had increased CSF protein levels. 2 out of 17 patients who did not have signs and symptoms of CNS involvement had elevated both CSF LDH and CSF protein levels. The increased levels came down to normal reference range after chemotherapy except in one patient in whom CSF LDH remained high. However, no significant change in CSF electrolytes (Na+, K+ and Cl-) was noted in these patients both before and after chemotherapy.
Raised CSF LDH and protein levels may indicate CNS involvement and can be used as markers for evaluation of CNS involvement in patients with ALL. To estimate serum copper levels and its correlation with the liver functionsin AD. Further, to measure the level of serum ceruloplasmin to assess the ceruloplasmin-copper relationship in AD.
27-probable AD (mean age 60 yrs) & 30 cognitive normal individuals (mean age 54 yrs) were taken inthe study. The two groups were matched for sex and age. The AD patient's sample consisted of individuals who fulfilled the NINDS-ADARD criteria and had MMSE score less than 26. All the patients with recent history of alcohol abuse were excluded from the test and control groups. The control sample consisted of elderly individuals attending the hospitals with ailment other than cognitive impairement. The study was done in patients coming to clinics routinely for dementia or other neurological disease. All participants underwent assays for copper, ceruloplasmin, and liver enzymes along with routine laboratory tests. All biochemical tests were automated on a XL-300 (Transasia) and performed in duplicte.
The mean copper level in AD was 148 + 26 μg/dL that ws significantly higher when compared to control (124 + 25 μg/dL). Serum copper level in AD showed no correlation with the serum ceruloplasmin (r = -0.273, p = 0.289) and liver enzyme alanine transminase (r = 0.336, p = 0.087) levels indicating that raised copper levels are independent of liver function and ceruloplasmin level.
It can be concluded from the present study that elevation of serum copper may be a consequence of the disease & not related to the poor liver function in old age and is independent of ceruloplasmin level and can be used as phenotypic marker in diagnosis in AD. 28 young, healthy male volunteers were randomized to two groups performing computer administered versions of WCST (N = 13) or IGT (N = 15). Serum Cortisol (CORT), total cholesterol (TC), high density lipoprotein cholesterol (HDL), low density lipoprotein cholesterol (LDL), very low density lipoprotein cholesterol (VLDL) and triglycerides (TG) responses were determined as the difference between post-task and pre-task basal levels.
There was a significant increase in the serum cortisol during performance of IGT from a basal pre-task level of 7.78 ± 0.45 (Mean ± SEM) to a post-task level of 8.85 ±0.66 (Mean ± SEM) (p < 0.05, N =15, paired samples Student's t test). The Serum cortisol response to WCST was not significant. There were no significant changes in TC, LDL or HDL for both the tasks.
The greater serum cortisol response to IGT suggests that it activates the HPA axis to greater extent and is presumably more stressful. The differences in neural connectivity and functional specialization of VMPFC and DLPFC may explain the differential activation of HPA by these two tasks.
